“Tythonic has achieved unprecedented success in 2020, and this quarter was no different despite a lull in new launches. Following the popular reception of Tythonus Prosthetics in Q4 2019, our research and development team turned their attention to an area that has long captured the interest of Tythonic: life extension.
While we were not yet prepared to share our findings this quarter, we are eager to provide our shareholders with additional information in the upcoming months. Our dedication to improving our existing solutions and the continued support of our investors keeps us on track to achieve our 2020 financial targets.”
